Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo
    Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management
    Release Date:
    Partner: Beijing Guangda Precision Medicine Research Center
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology China
    Optimizing Antimicrobial Stewardship Program in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Saudi Arabia
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Germany, Israel, Italy, Spain, Switzerland
    PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine
    Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of
    The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China, Hong Kong
    COVID-19 Disease Burden on the High Risk Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    2023/2024 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East Asia
    Release Date:
    Partner: Conquer Cancer®, the ASCO Foundation
    Review Process: Expert Review Panel
    Quality Improvement Oncology Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam
    Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and Opportunities
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Improving Care for Patients with Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    HRRm Testing in Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Advancing Oncology Education for Healthcare Professionals
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Djibouti, Gabon, Guinea, Madagascar, Mali, Niger, Rwanda, Senegal, Seychelles, Togo
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Japan
    Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Addressing Gaps in Care for Patients with Multiple Myeloma (Europe)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa
    Release Date:
    Partner: Conquer Cancer®, the ASCO Foundation
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation: Portuguese (link)
    Quality Improvement Oncology Congo, The Democratic Republic, Ethiopia, Ghana, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe